The Billion Dollar Molecule: One Company's Quest for the Perfect Drug. Cet article n’est pas disponible.The Billion Dollar Molecule: One Company's Quest for the Perfect Drug

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research.

Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing—atom by atom—both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS.

You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.

Barry Werth is an award-winning journalist and the author of eight books. His landmark first book, The Billion-Dollar Molecule, recounts the founding and early struggles of a startup pharmaceutical company, Vertex, in its quest for the perfect drug. His sequel, The Antidote, continues the story of Vertex as it emerges as a leader in delivering breakthrough medicines. The Age of Cures, the final book in his trilogy, introduces readers to the founding visionaries of the pharmaceutical revolution. Werth’s articles have appeared in The New Yorker, The New York Times Magazine, and GQ, among other publications. He has taught journalism and nonfiction writing at Smith College, Mount Holyoke College, and Boston University. He lives in Northampton, Massachusetts.